Guiomar Mendieta Badimon @Guio1212 X Profile

Guiomar Mendieta Badimon

@Guio1212

Followers

447

Following

3K

Media

9

Statuses

237

MD, PhD, MSc. Cardiologist @HospitalSantPau. Clinical scientist @CNIC_CARDIO. Coordinator of the Cardiac Rehabilitation and Secondary Prevention WG @catcardio.

Joined August 2014

Don't wanna be here? Send us removal request.

Lucía Matute

@lucia_matute

21 days

Ponencia muy inspiradora de @Guio1212 “Impacto de la SEC en la formación del Cardiólogo Científico Clínico en España” #SEC25

1

4

12

RTVE Notícies

@rtvenoticies

2 months

🫀 Dia Mundial del Cor: les malalties cardiovasculars són la primera causa de mort al món, amb 18 milions de víctimes anuals. 🎙️ @miremoreno6 | @radio4_rne @Guio1212 https://t.co/e0UTwemKs4

rtve.es

Guiomar Mendieta, cardiòloga, explica com prevenir malalties cardiovasculars i millorar la qualitat de vida en el Dia Mundial del Cor.

1

4

5

Edina Cenko

@EdinaCenko

3 months

💔 CVD causes >40% of deaths in Europe. Yet not everyone benefits equally from prevention, diagnosis & treatment. 📢 The @LancetRH_Europe Series on CVD Inequalities will be presented at #ESCCongress 2025 (Aug 29, Madrid) 👉 https://t.co/LorSR9yiKF

0

1

5

Francesco Costa

@Costa_F_8

4 months

AI is set to optimise CV pharmacotherapy but rigorous validation is essential 🙏🏷️ @DrDoblas @AranchaDiazEx @MariannaAdamo1 @Fabri84Dascenzo @koltowski @lucasabaITA @Guio1212 @FeliceGragnano @paolocalabro1 @lbadimon @Borjaibanez1 @Drroxmehran #Angiolillo @cardiotfl @DFCapodanno

0

9

13

Giovanni Occhipinti

@drgocchipinti

4 months

Tailoring #DAPT strategies based on #sex? Findings from our meta-analysis: ∘ DAPT discontinuation reduced MACE by 14% in #females, with no impact in #men. ∘ DAPT discontinuation reduced bleeding in males, not in #females. ∘ Aspirin-free DAPT discontinuation ranked first in

2

11

25

Soc Esp Cardiología

@secardiologia

6 months

Muchas gracias @rne ❤️por visibilizar la insuficiencia cardiaca. En España, casi 770.000 personas conviven con esta enfermedad que hace que incluso dormir se convierta en un reto. Sonia Mirabet, presidenta la Asociación de IC de la SEC, explica el impacto en la calidad de vida

0

11

22

Soc Esp Cardiología

@secardiologia

6 months

🏁Arranca el #CardioTV 'Optimización de la estrategia preventiva tras un evento cardiovascular' con la intervención de Guiomar Mendieta (@Guio1212). 💻Sigue en directo esta sesión de #CVVT2025 en https://t.co/ncv10rlOrW

0

2

6

Soc Esp Cardiología

@secardiologia

6 months

⏳Ya queda menos para el #CardioTV 'Optimización de la estrategia preventiva tras un evento cardiovascular', del ciclo #CVVT2025 📲Síguelo en directo hoy a las 17 h en https://t.co/ncv10rlOrW y pregunta a los ponentes

0

6

13

Marga Calvo López

@MargaCalvo2

1 year

Arrancan las Jornadas de enfermedad ateroesclerosis subclínica del @hospitaldelmar con magníficas ponencias @miguelcainzos23 @rfreixap @Guio1212 @EmilioOrtegaMdV Vamos allá con la prevención 1.5! 🙌🏻🫀🩺

0

6

15

John M. Clymer

@JohnClymer

1 year

Worldwide, women face health inequities: * Under-represented in clinical trials * Receive guideline-directed healthcare less than men * Face extra socioeconomic challenges Powerful panel at @GlobalHeartHub’s Unite Summit today. #GHHUnite

0

3

8

Harriette Van Spall, MD MPH 🇨🇦

@hvanspall

1 year

Tour de force GR from @VladoPerkovic, a master trialist whose contributions have shaped class I Guideline recs for 3 #CKM tx classes‼️ In pts w DM & CKD, #semaglutide ⬇️ prim comp kidney outcome + hier’l #eGFR slope, #MACE, #ACM #RAASi #SGLT2i #nsMRA #GLP1RA = core CKM pillars

Harriette Van Spall, MD MPH 🇨🇦

@hvanspall

1 year

Delighted to host Professor @VladoPerkovic virtually for #McMaster CV Regional Grand Rounds “#CardioKidneyMetabolic Disease: Trials and Tribulations” Tuesday, Oct 8, 2024, 8 am EST Via your Zoom link #CKM #Prevention #Diabetes #CKD Bio: https://t.co/5Z1MsAouT1

1

14

36

EHJ Editor-in-Chief

@ehj_ed

1 year

EHJ Dialogue with Prof. Patrono on the past, present, and future of aspirin

1

5

9

Miguel Cainzos-Achirica

@miguelcainzos23

1 year

Las guías ESC 2024 recomiendan, cada vez con mayor evidencia, el uso del TC coronario en el dolor torácico estable. Y con recomendación IIa, utilizar la presencia de calcificaciones coronarias incidentales para intensificar el tto preventivo El 15 de Noviembre os esperamos [1/3]

2

13

25

The BMJ

@bmj_latest

1 year

Patient related outcomes, with their specific focus on a person’s lived experience, are increasingly receiving attention in healthcare settings. @AjjanRamzi, and colleagues look at the benefits they could bring to people with long term conditions https://t.co/uMZbqIzrz4

bmj.com

Measuring patient related outcomes helps to assess the effects of treatment on patients and can facilitate personalised care, say Ramzi Ajjan and colleagues In most consultations about long term...

1

20

50

José Javier Fuster

@josejfuster

1 year

And another paper online simultaneously with #ESCCongress! With Dr. Valentin Fuster and colleagues @CNIC_CARDIO, we clarify the relationship between clonal hematopoiesis and atherosclerosis. @NatureMedicine https://t.co/4bYVH9ZBzt More details ➡️ https://t.co/ob4nfA8fku

29

44

169

Alberto Cordero

@acorderofort

2 years

Recombinant human soluble domain of CD39L3 and ticagrelor: cardioprotective effects in experimental myocardial infarction ⤵️myocardial oedema ⤴️higher LVEF improvement 📢new therapy on top of ticagrelor Congrats Gemma Vilhaur and @linabadimon https://t.co/08nIwSGG7w

academic.oup.com

AbstractBackground and Aims. The ecto–nucleoside triphosphate diphosphohydrolases of the CD39 family degrade ATP and ADP into AMP, which is converted into

0

2

José R. Juanatey

@JoseJuanatey

2 years

Guiomar Mendieta Badimon @Guio1212 en las sesiones @cardiologiaCHUS y Cardio 12 de Octubre hablando de las implicaciones clínicas de la ateroesclerosis subclinica! La excelencia de la nueva generación de cardiólogos!! @secardiologia @idibaps @CIBER_CV

3

5

49

Felipe García Calvo

@FelipeGarcaCal1

2 years

📸 En directo desde o @cardiologiaCHUS @Guio1212 do Hospital Clínic Barcelona discute a Ateroesclerose subclínica e as súas implicacións clínicas. Únete á nosa sesión agora! 🏥👩‍⚕️ 🔗 Mira a transmisión en vivo aquí: https://t.co/3rtnRSCaa9 https://t.co/3rtnRSCaa9 vía @YouTube

1

6

Giuseppe Biondi-Zoccai

@gbiondizoccai

2 years

Josep Iglesies-Grau, from the Montreal Heart Institute, takes the stage for an award-winning presentation 'Early insulin resistance in low-risk subjects with normal glycemia is associated with subclinical atherosclerosis' at #ESCPrev2024 @EAPCPresident @jiglesies1

5

6

24

Otavio Berwanger

@OtavioBerwanger

2 years

Why diversity is needed at every level of clinical trials, from participants to leaders | Nature Medicine

0

1

6